We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$34.3M
Cap. Flow
-$33.3M
Cap. Flow %
-33.2%
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
32
Reduced
107
Closed
85

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$5.08M
2
UNH icon
UnitedHealth
UNH
+$4.05M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.82M
4
NVO
Novo Nordisk
NVO
+$2.52M
5
ABBV icon
AbbVie
ABBV
+$2.39M

Top Sells

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$4.32M
2
HRMY icon
Harmony Biosciences
HRMY
+$3.88M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$3.12M
4
EFC
Ellington Financial
EFC
+$2.6M
5
MTG icon
MGIC Investment
MTG
+$2.54M

Sector Composition

Rank Sector Weight
1 Healthcare 54.58%
2 Real Estate 7.4%
3 Industrials 5.96%
4 Financials 5.87%
5 Technology 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
51
Cigna
CI
$74.5B
$543K 0.54%
+1,965
New +$626K
XMTR icon
52
Xometry
XMTR
$5.44B
$533K 0.53%
+12,500
New +$354K
CHE icon
53
Chemed
CHE
$6.77B
$520K 0.52%
+982
New +$554K
NEOG icon
54
Neogen
NEOG
$2.24B
$519K 0.52%
+42,737
New +$598K
PFX icon
55
PhenixFIN
PFX
$88.7M
$507K 0.51%
+10,300
New +$493K
NBIX icon
56
Neurocrine Biosciences
NBIX
$17.2B
$503K 0.5%
3,684
-18,816
-84% -$2.33M
SNPS icon
57
Synopsys
SNPS
$73.6B
$485K 0.48%
1,000
– –
USPH icon
58
US Physical Therapy
USPH
$1.12B
$479K 0.48%
+5,404
New +$482K
SYM icon
59
Symbotic
SYM
$5.25B
$474K 0.47%
20,000
-5,000
-20% -$142K
UAL icon
60
United Airlines
UAL
$37.5B
$465K 0.46%
4,793
-420
-8% -$35.5K
HIG icon
61
Hartford Financial Services
HIG
$38.4B
$459K 0.46%
4,199
-252
-6% -$29.2K
LUNR icon
62
Intuitive Machines
LUNR
$2.17B
$454K 0.45%
25,000
+10,000
+67% +$111K
CDNS icon
63
Cadence Design Systems
CDNS
$91B
$451K 0.45%
1,500
+250
+20% +$72.7K
COST icon
64
Costco
COST
$417B
$444K 0.44%
485
-14
-3% -$13K
ICLR icon
65
Icon
ICLR
$13.1B
$412K 0.41%
+1,965
New +$459K
JPM icon
66
JPMorgan Chase
JPM
$907B
$407K 0.41%
1,696
-104
-6% -$24.2K
WSR
67
DELISTED
Whitestone REIT
WSR
$403K 0.4%
+28,470
New +$406K
L icon
68
Loews
L
$23.6B
$403K 0.4%
4,757
-196
-4% -$16.2K
ZTS icon
69
Zoetis
ZTS
$32.1B
$400K 0.4%
+2,456
New +$439K
VZ icon
70
Verizon
VZ
$182B
$400K 0.4%
+10,000
New +$422K
RSG icon
71
Republic Services
RSG
$68.4B
$396K 0.39%
1,967
-53
-3% -$11K
PBP icon
72
Invesco S&P 500 BuyWrite ETF
PBP
$348M
$391K 0.39%
16,573
+779
+5% +$18K
AVAV icon
73
AeroVironment
AVAV
$7.2B
$385K 0.38%
2,500
– –
BKLN icon
74
Invesco Senior Loan ETF
BKLN
$7.19B
$384K 0.38%
18,245
+1,229
+7% +$25.9K
DAL icon
75
Delta Air Lines
DAL
$55.4B
$381K 0.38%
6,303
-648
-9% -$38.3K
1 2
3
4 5

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, AlphaCentric Advisors held 294 positions worth $100M, down 25% from $135M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

AlphaCentric Advisors withdrew a net $33.3M in Q4 2024, closing 85 positions and reducing 107 holdings. Its most notable exit was Rithm Capital, an estimated $4.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 58% a quarter earlier, followed by Real Estate and Industrials.

Against the trend, AlphaCentric Advisors opened a new position in Eli Lilly worth $4.74M.

  • AlphaCentric Advisors's largest Q4 2024 buy was Eli Lilly: 6,140 shares worth $4.74M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.03M increase.
  • AlphaCentric Advisors's biggest Q4 2024 reduction was Neurocrine Biosciences, cutting an estimated $2.33M.
  • AlphaCentric Advisors fully exited Rithm Capital in Q4 2024, selling an estimated $4.32M.
  • AlphaCentric Advisors's ten largest holdings make up 26% of its $100M portfolio in Q4 2024.
  • AlphaCentric Advisors opened 64 new positions and closed 85 in Q4 2024.
  • AlphaCentric Advisors's portfolio value fell 25% quarter-over-quarter to $100M.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.